Location: Austin, TX
CIK: 0001019231 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 4, 2022
Total Value: $231M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBRE | JPM BETABLDRS MSCI US REIT | 2,175,631 | $191M | 82.7% | $99.45 | — | ETFS | 46641Q738 |
| — | ELLIOTT OPPORTUNITY II CORP | 2,000,000 | $19.6M | 8.5% | $10.01 | — | COM | G30092129 |
| IMTX | IMMATICS NV | 697,431 | $6.075M | 2.6% | $10.53 | -24.9% | COM | N44445109 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $4.917M | 2.1% | $57.24 | +163.8% | COM | 882508104 |
| VT | VANGUARD TOT WORLD STK ETF | 29,585 | $2.525M | 1.1% | $80.77 | — | ETFS | 922042742 |
| WTTR | SELECT ENERGY SERVICES INC | 368,829 | $2.515M | 1.1% | $6.82 | — | COM | 81617J301 |
| — | CODIAK BIOSCIENCES INC | 847,108 | $2.44M | 1.1% | $15.08 | — | COM | 192010106 |
| BOND | PIMCO ACTIVE BOND EXCHANGE-T | 15,502 | $1.477M | 0.6% | $107.83 | — | COM | 72201R775 |
| — | PLX PHARMA INC | 62,673 | $152K | 0.1% | $6.14 | — | COM | 72942A107 |
| — | TFF PHARMACEUTICALS INC | 22,066 | $125K | 0.1% | $18.47 | — | COM | 87241J104 |
| — | AEGLEA BIOTHERAPEUTICS INC | 245,678 | $124K | 0.1% | $6.41 | — | COM | 00773J103 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $66,000 | 0.0% | $7.34 | -74.0% | COM | 528872302 |
| — | APOLLO ENDOSURGERY INC | 15,601 | $57,000 | 0.0% | $2.24 | — | COM | 03767D108 |
| MSFT | MICROSOFT CORP | 44 | $11,000 | 0.0% | $290.64 | -9.4% | COM | 594918104 |
| GOOG | ALPHABET INC | 4 | $9,000 | 0.0% | $117.28 | 0.0% | COM | 02079K107 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $6,000 | 0.0% | $20.00 | +111.5% | COM | 736508847 |
| PEP | PEPSICO INC | 6 | $1,000 | 0.0% | $149.80 | 0.0% | COM | 713448108 |